Long-term administration of quarterly IV ibandronate is effective and well tolerated in postmenopausal osteoporosis: 5-year data from the DIVA study long-term extension

No Thumbnail Available

Authors

Bianchi, G.
Czerwinski, E.
Kenwright, A.
Burdeska, A.
Recker, R. R.
Felsenberg, D.

Issue Date

2012

Type

Journal Article

Language

Keywords

Research Projects

Organizational Units

Journal Issue

Alternative Title

Abstract

Description

Citation

Bianchi, G.; Czerwinski, E.; Kenwright, A.; Burdeska, A.; Recker, R. R.; Felsenberg, D. Long-term administration of quarterly IV ibandronate is effective and well tolerated in postmenopausal osteoporosis: 5-year data from the DIVA study long-term extension. Osteoporosis International. 2012, 23(6):1769-1778.

Publisher

License

Journal

Volume

Issue

PubMed ID

DOI

ISSN

1433-2965
0937-941X

EISSN